Literature DB >> 11179617

Grey-scale contrast enhancement in rabbit liver with DMP115 at different acoustic power levels.

H Maruyama1, S Matsutani, H Saisho, N Kamiyama, H Yuki, K Miyata.   

Abstract

The contrast enhancement effect of ultrasound (US) contrast agent DMP-115 (YM454, Definity) in rabbit liver at two acoustic transmit power levels was studied. A total of 12 rabbits with healthy livers and 7 rabbits with VX-2 tumors were used. Grey-scale ultrasonograms in both fundamental (3.75 MHz) and harmonic (2.5/5.0 MHz) imaging modes were performed at a frame rate of 26 Hz under baseline acoustic power (MI = 0.6) or lower acoustic power (MI = 0.2). The contrast enhancement depended on the contrast agent dose and the acoustic power. The video intensity change was higher in the portal vein under the baseline acoustic power and higher in the liver parenchyma under the lower acoustic power. The contrast-enhanced US observation of the VX-2 tumor in the arterial phase correlated well with the angiographic and histopathological appearance of the tumor. In the parenchymal phase, the borderline of the tumor could be clearly delineated from the surrounding liver parenchyma. Continuous fundamental and harmonic grey-scale imaging with DMP115 has the capability of making peripheral circulation images of liver parenchyma and tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11179617     DOI: 10.1016/s0301-5629(00)00266-0

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  2 in total

Review 1.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

2.  Quantitative assessment of renal damage in rhesus monkeys with diabetic nephropathy using contrast-enhanced ultrasound.

Authors:  Wenwu Ling; Yulan Peng; Hong Wang; Xingxing An; Yanrong Lu
Journal:  Ann Transl Med       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.